Table 12.6e

Immunosuppression Use for Maintenance

		Year of Transplant
		2000	2001	2002	2003	2004	2005	2006	2007	2008	2009
Functioning Graft at Discharge		859	951	947	1,013	1,107	1,284	1,299	1,359	1,369	1,552
With Immunosuppression Info		855	948	942	1,009	1,097	1,268	1,293	1,337	1,357	1,547
Corticosteroids	Any in Category	97.8%	98.9%	98.6%	94.4%	97.2%	97.9%	97.5%	95.4%	98.2%	98.2%
Corticosteroids	Steroids	97.8%	98.9%	98.6%	94.4%	97.2%	97.9%	97.5%	95.4%	98.2%	98.2%
Cyclosporine	Any in Category	61.9%	52.1%	42.5%	34.6%	29.7%	22.2%	16.2%	10.4%	8.5%	7.8%
	Cyclosporin	0.0%	0.4%	0.2%	0.2%	0.2%	0.5%	1.1%	1.1%	0.9%	0.1%
	Sandimmmune	6.9%	5.7%	4.5%	4.8%	2.1%	1.7%	1.6%	0.7%	0.7%	1.4%
	Neoral	53.9%	39.3%	31.0%	23.0%	20.4%	15.0%	9.4%	7.2%	6.0%	5.0%
	Gengraf	1.1%	6.2%	6.7%	6.5%	6.7%	4.8%	4.2%	1.3%	0.8%	0.8%
	Eon	0.0%	0.4%	0.1%	0.1%	0.3%	0.2%	0.0%	0.0%	0.1%	0.5%
Tacrolimus	Any in Category	38.2%	49.4%	57.2%	65.4%	69.9%	76.2%	82.6%	88.1%	90.4%	89.3%
	Tacrolimus	38.2%	49.4%	57.2%	65.4%	69.9%	76.2%	82.5%	87.2%	89.2%	88.8%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	1.2%	0.5%
Antimetabolites	Any in Category	93.7%	91.8%	91.1%	89.6%	90.6%	92.0%	92.7%	92.3%	91.5%	87.8%
	Mycophenolate Mofetil	35.7%	41.4%	45.1%	43.5%	46.8%	51.7%	51.9%	54.5%	54.5%	50.9%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	2.1%	2.5%	6.4%	8.7%	7.4%
	Azathioprine	57.8%	50.2%	45.8%	46.1%	43.8%	38.2%	38.4%	31.4%	28.3%	29.5%
	Leflunomide	0.1%	0.1%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
	Cytoxan	0.1%	0.1%	0.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	2.7%	4.2%	1.9%	1.1%	1.3%	0.6%	1.7%	0.2%	0.4%	0.4%
	Sirolimus	2.7%	4.2%	1.9%	1.1%	1.3%	0.6%	1.7%	0.2%	0.4%	0.4%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%